glp-1 agonists for obesity Weight Reduction with and Paths Discontinuation While Maintaining Weight Loss GLP-1 Receptor Agonist Market Growth
Description
Proton Pump Inhibitors (PPIs) Example: Omeprazole, Nexium, Prevacid Block stomach acid, which further reduces absorption of B12, magnesium, iron, and calcium Can worsen fatigue, muscle cramps, or brain fog Ask your provider whether long-term use is still necessary and monitor your nutrient levels regularly

Theyre also, for the most part, temporary as you adjust to the medication
struggle with their weight and are classified as obese
People who are obese (have a BMI greater than or equal to 30) are clinically eligible for GLP-1 drugs, but employer plans may set additional BMI requirements to cover GLP-1 drug use under obesity

2024;385 doi: 10.1136/bmj-2023-078225
